Page:United States Statutes at Large Volume 124.djvu/2815

 124 STAT. 2789 PUBLIC LAW 111–264—OCT. 8, 2010 Public Law 111–264 111th Congress An Act To amend the Stem Cell Therapeutic and Research Act of 2005. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ‘‘Stem Cell Therapeutic and Research Reauthorization Act of 2010’’. SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005. (a) CORD BLOOD INVENTORY.—Section 2 of the Stem Cell Thera- peutic and Research Act of 2005 (42 U.S.C. 274k note) is amended— (1) in subsection (a), by inserting ‘‘the inventory goal of at least’’ before ‘‘150,000’’; (2) in subsection (c)— (A) in paragraph (2), by striking ‘‘or is transferred’’ and all that follows through the period and inserting ‘‘for a first-degree relative.’’; and (B) in paragraph (3), by striking ‘‘150,000’’; (3) in subsection (d)— (A) in paragraph (1), by inserting ‘‘beginning on the last date on which the recipient of a contract under this section receives Federal funds under this section’’ after ‘‘10 years’’; (B) in paragraph (2), by striking ‘‘; and’’ and inserting ‘‘;’’; (C) by redesignating paragraph (3) as paragraph (5); and (D) by inserting after paragraph (2) the following: ‘‘(3) will provide a plan to increase cord blood unit collec- tions at collection sites that exist at the time of application, assist with the establishment of new collection sites, or contract with new collection sites; ‘‘(4) will annually provide to the Secretary a plan for, and demonstrate, ongoing measurable progress toward achieving self-sufficiency of cord blood unit collection and banking operations; and’’; (4) in subsection (e)— (A) in paragraph (1)— (i) by striking ‘‘10 years’’ and inserting ‘‘a period of at least 10 years beginning on the last date on which the recipient of a contract under this section receives Federal funds under this section’’; and Deadline. Plans. Plans. 42 USC 201 note. Stem Cell Therapeutic and Research Reauthorization Act of 2010. Oct. 8, 2010 [S. 3751]